SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-23-305968
Filing Date
2023-12-29
Accepted
2023-12-29 16:10:30
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-1/A d613667ds1a.htm S-1/A 407802
2 EX-1.1 d613667dex11.htm EX-1.1 191998
3 EX-4.4 d613667dex44.htm EX-4.4 92601
4 EX-5.2 d613667dex52.htm EX-5.2 8339
5 EX-23.1 d613667dex231.htm EX-23.1 3625
6 EX-FILING FEES d613667dexfilingfees.htm EX-FILING FEES 34037
7 GRAPHIC g613667dsp62.jpg GRAPHIC 10098
8 GRAPHIC g613667g1202020638135.jpg GRAPHIC 3681
  Complete submission text file 0001193125-23-305968.txt   759059
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-275870 | Film No.: 231527774
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)